Blog: 23andMe vs. the FDA part 2 – analyzing the science
This blog post was written by Deniz Temelli, Business Analyst at TechAlliance. Early last December, the Google-backed personal genetics company 23andMe was ordered to stop marketing and selling its Personal Genome Service by the FDA. You can read the details of why in my last blog post. The fall out and debate surrounding this decision…